Applied Clinical Trials
June 01, 2018
Feature Article
27
6
A look at home and dosing site considerations.
June 01, 2018
From the Editor
27
6
Editor-in-Chief Lisa Henderson speak about therapeutic needs, rare diseases in children, and the SCORR Marketing survey on innovative or flexible trial designs.
June 01, 2018
Feature Article
27
6
Findings from a new ACT and SCORR Marketing survey reveal the most actively used flexible design approaches in clinical research-many with application in rare disease.
June 01, 2018
News
27
6
Leader of one longtime CRO discusses the marked changes in clinical trial practice from past to present-and the company’s unique focus.
June 01, 2018
News
27
6
Jill Wechsler details the continued rise of incorporating the “patient experience” in drug development measures.
June 01, 2018
Feature Article
27
6
Exploring three distinct patient partnership models to help researchers assess which methods of engagement could work best for their clinical programs.
June 01, 2018
A Closing Thought
27
6
With more common cancers now increasingly broken down by specific genomic defects, the future of research for any cancer is entirely, and unequivocally, molecular.
June 01, 2018
Feature Article
27
6
Outlining the unique pharmacokinetic factors that should be considered when designing and running early stage clinical trials for monoclonal antibodies.
June 01, 2018
Clinical Trial Insights
27
6
Sobering statistics collected on clinical trial execution point to the eventual convergence of healthcare and clinical research operating environments.
June 01, 2018
News
27
6
Peter O’Donnell explores the convergence of policy and science in new vaccine R&D pursuits in Europe.
June 01, 2018
Issue PDF
27
6
Click the title above to open the Applied Clinical Trials June 2018 issue in an interactive PDF format.
January 17, 2018
Feature Article
27
6
Case study demonstrates that site activation is a key driver in determining patient enrollment cycle time.